...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells.
【24h】

Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells.

机译:造血干细胞移植后FoxP3 + CD4 + 25 +调节性T细胞的诱导:骨髓源性促进细胞的作用。

获取原文
获取原文并翻译 | 示例

摘要

The establishment of donor cell lineages following allogeneic bone marrow transplantation is frequently associated with the development of graft-vs-host disease (GVHD). The identification of cell populations that are capable of supporting allogeneic stem cell (SC) engraftment and the induction of tolerance without inducing GVHD could expand the use of this therapy. CD8(+)TCR(-) facilitating cells (FC) have been shown to promote allogeneic SC engraftment with resulting transplantation tolerance across complete MHC barriers without inducing GVHD. Although donor reconstitution in SC plus FC recipients is associated with the induction of regulatory T cell-associated factors, it is not known whether an induction of regulatory T cells and subsequent tolerance is a direct effect of the FC. The current study demonstrates that 1) SC plus FC transplantation results in the induction of donor CD4(+)25(+) regulatory T cells and that FC are present in the spleen of recipients before the induction of these cells, 2) activation of FC with CpG-oligodeoxynucleotide promotes CD4(+)25(-) T cell differentiation into CD4(+)25(+) regulatory T cells in vitro, as demonstrated by cytokine and forkhead/winged helix transcription factor (FoxP3) gene and protein expression, and 3) direct contact between FC and CD4(+)25(-) T cells is required for FoxP3(+)CD4(+)25(+) regulatory T cell induction and is dependent on CD86 expression on FC. This is the first report to demonstrate a mechanism for FC in the induction of regulatory T cells following allogeneic SC plus FC transplantation. The transplantation of donor FC may provide an alternative approach to permit clinical SC engraftment and induction of transplantation tolerance in the future.
机译:同种异体骨髓移植后供体细胞谱系的建立通常与移植物抗宿主病(GVHD)的发展有关。能够支持同种异体干细胞(SC)植入并诱导耐受而不诱导GVHD的细胞群的鉴定可以扩大这种疗法的应用。已显示CD8(+)TCR(-)促进细胞(FC)可以促进同种异体SC移植,从而在不诱导GVHD的情况下跨完整的MHC壁垒产生移植耐受性。尽管SC加FC受体的供体重建与调节性T细胞相关因子的诱导有关,但尚不清楚诱导调节性T细胞和随后的耐受性是否是FC的直接作用。目前的研究表明,1)SC加FC移植可诱导供体CD4(+)25(+)调节性T细胞的诱导,并且FC在诱导这些细胞之前存在于受体的脾脏中; 2)FC的激活CpG-寡聚脱氧核苷酸可在体外促进CD4(+)25(-)T细胞分化为CD4(+)25(+)调节性T细胞,如细胞因子和叉头/翅螺旋转录因子(FoxP3)基因和蛋白质表达所证明,和3)FoxP3(+)CD4(+)25(+)调节性T细胞诱导需要FC与CD4(+)25(-)T细胞直接接触,并且依赖于FC上CD86的表达。这是第一份证明同种异体SC加FC移植后FC诱导调节性T细胞的机制的报告。供体FC的移植可提供替代方法,以允许将来进行临床SC移植和诱导移植耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号